No matches
Dermatology

ADVENT at 2025 IDS LearnSkin Summer Congress

Join ADVENT at the 2025 IDS LearnSkin Summer Symposium!
Sarina Elmariah
David Cotter
MD, PhD
Sarina Elmariah +1 more
ADVENT at IDS LearnSkin 2025
 - 
In progress
Location
El Conquistador Hilton
10000 N Oracle Rd 85704 Tucson, AZ United States

Symposium Details

August 24

Type 2 Inflammation: The Common Thread in AD, PN, and CSU—Unraveling Itch and Disease Burden

Join experts Drs. Sarina Elmariah and David Cotter at an ADVENT educational symposium at IDS 2025 where they will discuss disease burden and diagnosis in AD, PN, and CSU, highlighting the underlying role of type 2 inflammation in disease pathophysiology and itch.

Agenda

Learning objectives

  • Describe the role of type 2 inflammation in the pathogenesis of AD, PN, and CSU, highlighting shared and distinct mechanisms
  • Examine the role of type 2 inflammation in driving chronic itch
  • Explain the shared and unique burdens of AD, PN, and CSU

Location

El Conquistador Hilton
10000 N Oracle Rd 85704 Tucson, AZ United States
Check on Google Maps
Tags
type 2 inflammationitchpatient burden
MAT-US-2509816 v1.0 - P Expiration Date: 08/25/2027

Speakers

Dermatology
MD, PhD

Sarina Elmariah

Associate Professor and Dermatology Director at the UCSF Centre for Itch and Neurosensory Disorders at the University of California in San Francisco, California, US

David Cotter
Dermatology
MD, PhD

David Cotter

Assistant Clinical Professor, UNLV School of Medicine

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2025 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-US-2305040 v3.0-P Exp. Date: 11/24/2025

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: United StatesChange country/region